AIG
ENTA icon

American International Group’s Enanta Pharmaceuticals ENTA Stock Holding History

American International Group’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,985
Closed -$174K – 852
2024
Q1 		$174K Buy
9,985
+43
+0.4% +$569 ﹤0.01% 2228
2023
Q4 		$93.6K Sell
9,942
-40
-0.4% -$373 ﹤0.01% 2599
2023
Q3 		$111K Sell
9,982
-746
-7% -$12K ﹤0.01% 2446
2023
Q2 		$230K Sell
10,728
-131
-1% -$3.86K ﹤0.01% 2087
2023
Q1 		$439K Buy
10,859
+222
+2% +$10.6K ﹤0.01% 1672
2022
Q4 		$495K Sell
10,637
-83
-0.8% -$3.78K ﹤0.01% 1599
2022
Q3 		$556K Buy
10,720
+194
+2% +$11.3K ﹤0.01% 1509
2022
Q2 		$498K Sell
10,526
-592
-5% -$32.1K ﹤0.01% 1611
2022
Q1 		$791K Sell
11,118
-499
-4% -$32.5K ﹤0.01% 1473
2021
Q4 		$869K Sell
11,617
-371
-3% -$29.1K ﹤0.01% 1511
2021
Q3 		$681K Sell
11,988
-407
-3% -$20.1K ﹤0.01% 1655
2021
Q2 		$546 Sell
12,395
-318
-3% -$15.6K ﹤0.01% 1864
2021
Q1 		$627 Sell
12,713
-3
-0% -$150 ﹤0.01% 1713
2020
Q4 		$535 Sell
12,716
-321
-2% -$14.1K ﹤0.01% 1706
2020
Q3 		$597K Sell
13,037
-161
-1% -$7.8K ﹤0.01% 1504
2020
Q2 		$663K Buy
13,198
+403
+3% +$20.9K ﹤0.01% 1451
2020
Q1 		$658K Buy
12,795
+518
+4% +$27.6K ﹤0.01% 1296
2019
Q4 		$758K Sell
12,277
-312
-2% -$19.3K ﹤0.01% 1471
2019
Q3 		$756K Sell
12,589
-137
-1% -$10.2K ﹤0.01% 1437
2019
Q2 		$1.07M Buy
12,726
+187
+1% +$16.8K ﹤0.01% 1278
2019
Q1 		$1.2M Sell
12,539
-342
-3% -$30.7K ﹤0.01% 1228
2018
Q4 		$912K Sell
12,881
-145
-1% -$11.1K ﹤0.01% 1323
2018
Q3 		$1.11M Buy
13,026
+393
+3% +$39.4K ﹤0.01% 1375
2018
Q2 		$1.46M Buy
12,633
+2,712
+27% +$271K 0.01% 1157
2018
Q1 		$803K Sell
9,921
-2,266
-19% -$174K ﹤0.01% 1401
2017
Q4 		$715K Buy
12,187
+48
+0.4% +$2.4K ﹤0.01% 1567
2017
Q3 		$568K Buy
12,139
+726
+6% +$29.2K ﹤0.01% 1685
2017
Q2 		$411K Buy
11,413
+1,799
+19% +$57.5K ﹤0.01% 1827
2017
Q1 		$296K Sell
9,614
-1,556
-14% -$48.5K ﹤0.01% 1936
2016
Q4 		$374K Sell
11,170
-153
-1% -$4.39K ﹤0.01% 1819
2016
Q3 		$301K Buy
11,323
+99
+0.9% +$2.3K ﹤0.01% 1910
2016
Q2 		$247K Sell
11,224
-395
-3% -$10.3K ﹤0.01% 1995
2016
Q1 		$341K Buy
11,619
+484
+4% +$13.5K ﹤0.01% 2303
2015
Q4 		$368K Sell
11,135
-102
-0.9% -$3.32K ﹤0.01% 2279
2015
Q3 		$406K Buy
11,237
+1,656
+17% +$71.1K ﹤0.01% 2193
2015
Q2 		$431K Buy
9,581
+2,882
+43% +$112K ﹤0.01% 2313
2015
Q1 		$205K Buy
6,699
+100
+2% +$3.89K ﹤0.01% 2923
2014
Q4 		$336K Sell
6,599
-157
-2% -$7.03K ﹤0.01% 2484
2014
Q3 		$267K Sell
6,756
-5
-0.1% -$199 ﹤0.01% 2694
2014
Q2 		$291K Buy
6,761
+4,286
+173% +$163K ﹤0.01% 2651
2014
Q1 		$99K Buy
2,475
+59
+2% +$2.14K ﹤0.01% 3441
2013
Q4 		$65.9K Sell
2,416
-24
-1% -$582 ﹤0.01% 3637
2013
Q3 		$55.9K Buy
+2,440
New +$46.6K ﹤0.01% 3678

Other funds holding ENTA

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American International Group's ENTA Position: Q2 2024 in Review

American International Group sold out of Enanta Pharmaceuticals (ENTA) in Q2 2024, closing a stake of 9,985 shares — an estimated $174K sold.

American International Group first reported a position in ENTA in Q3 2013 and held it in 43 quarters. The position peaked at $1.46M in Q2 2018. 100 funds tracked by Wall St. Rank hold ENTA as of Q2 2024.

  • American International Group reported no remaining Enanta Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 9,985 Enanta Pharmaceuticals shares in Q2 2024, an estimated $174K.
  • American International Group first reported a position in Enanta Pharmaceuticals in Q3 2013 and held it in 43 quarters.
  • American International Group's Enanta Pharmaceuticals position peaked at $1.46M in Q2 2018.
  • 100 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.